Edition:
United States

Kun Run Biotechnology Inc (KURU.PK)

KURU.PK on OTC Markets Group

0.03USD
--
Change (% chg)

-- (--)
Prev Close
$0.03
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
$0.03
52-wk Low
$0.03

KURU.PK

Chart for KURU.PK

About

Kun Run Biotechnology, Inc. is engaged, through Hainan Zhonghe Pharmaceutical Co., Ltd. (Zhonghe), its China-based indirect subsidiary, in the development, manufacture, marketing and sale of prescription polypeptide drugs. The Company’s principal products are prescription polypeptide drugs used to treat immune system malfunction... (more)
No analyst recommendations are available for KURU.PK.

Overall

Beta: --
Market Cap(Mil.): $0.62
Shares Outstanding(Mil.): 25.00
Dividend: --
Yield (%): --

Financials

  KURU.PK Industry Sector
P/E (TTM): 0.15 28.47 29.39
EPS (TTM): 0.17 -- --
ROI: 15.08 13.57 13.06
ROE: 15.27 14.45 14.19

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.